Tissue ablation systems and methods of use Patent Grant Shadduck December 2, 2 [Shadduck; John H.]

Tissue ablation systems and methods of use

Shadduck December 2, 2

Patent Grant 8900223

U.S. patent number 8,900,223 [Application Number 12/941,778] was granted by the patent office on 2014-12-02 for tissue ablation systems and methods of use. This patent grant is currently assigned to Tsunami MedTech, LLC. The grantee listed for this patent is John H. Shadduck. Invention is credited to John H. Shadduck.

United States Patent	8,900,223
Shadduck	December 2, 2014

Tissue ablation systems and methods of use

Abstract

This invention relates to medical instruments and systems for applying energy to tissue. Variations of the systems and methods described herein include ablating, sealing, and extracting tissue with high pressure flows of fluids that in part utilizes a vapor-to-liquid phase change of flow media to apply thermal energy to the tissue.

Inventors:

Shadduck; John H. (Berkeley, CA)

Applicant:

Name	City	State	Country	Type
Shadduck; John H.	Berkeley	CA	US

Assignee:

Tsunami MedTech, LLC (Menlo Park, CA)

Family ID:

44011864

Appl. No.:

12/941,778

Filed:

November 8, 2010

Prior Publication Data


	Document Identifier	Publication Date
	US 20110118717 A1	May 19, 2011

Related U.S. Patent Documents


Application Number	Filing Date	Patent Number	Issue Date
61259097	Nov 6, 2009

Current U.S. Class:	606/27; 606/41; 606/28
Current CPC Class:	A61B 18/1477 (20130101); A61B 18/04 (20130101); A61B 2018/00434 (20130101); A61B 2018/00601 (20130101); A61B 2018/00589 (20130101); A61B 2018/048 (20130101); A61B 2018/1412 (20130101)
Current International Class:	A61B 18/18 (20060101)
Field of Search:	;606/27-32,41

References Cited [Referenced By]

U.S. Patent Documents


408899	August 1889	Bioch et al.
697181	April 1902	Smith
1719750	September 1927	Bridge et al.
3818913	June 1974	Wallach
3880168	April 1975	Berman
3930505	January 1976	Wallach
4024866	May 1977	Wallach
4083077	April 1978	Knight et al.
4447227	May 1984	Kotsanis
4672962	June 1987	Hershenson
4682596	July 1987	Bales et al.
4748979	June 1988	Hershenson
4773410	September 1988	Blackmer et al.
4793352	December 1988	Eichenlaub
4872920	October 1989	Flynn et al.
4898574	February 1990	Uchiyama et al.
4915113	April 1990	Holman
4950266	August 1990	Sinofsky
4985027	January 1991	Dressel
5006119	April 1991	Acker et al.
5011566	April 1991	Hoffman
5084043	January 1992	Hertzmann et al.
5102410	April 1992	Dressel
5112328	May 1992	Taboada et al.
5122138	June 1992	Manwaring
5158536	October 1992	Sekins et al.
5162374	November 1992	Mulieri et al.
5190539	March 1993	Fletcher et al.
5217459	June 1993	Kamerling
5217465	June 1993	Steppe
5263951	November 1993	Spears et al.
5277696	January 1994	Hagen
5298298	March 1994	Hoffman
5306274	April 1994	Long
5318014	June 1994	Carter
5331947	July 1994	Shturman
5334190	August 1994	Seiler
5344397	September 1994	Heaven et al.
5348551	September 1994	Spears et al.
5352512	October 1994	Hoffman
5417686	May 1995	Peterson et al.
5424620	June 1995	Cheon et al.
5433708	July 1995	Nichols et al.
5433739	July 1995	Sluijter
5462521	October 1995	Brucker et al.
5500012	March 1996	Brucker et al.
5503638	April 1996	Cooper et al.
5524620	June 1996	Rosenschein
5529076	June 1996	Schachar
5542928	August 1996	Evans et al.
5549628	August 1996	Cooper et al.
5554172	September 1996	Horner et al.
5562608	October 1996	Sekins et al.
5575803	November 1996	Cooper et al.
5584872	December 1996	LaFontaine et al.
5591157	January 1997	Hennings et al.
5591162	January 1997	Fletcher et al.
5616120	April 1997	Andrew et al.
5620440	April 1997	Heckele et al.
5669907	September 1997	Platt, Jr. et al.
5681282	October 1997	Eggers et al.
5683366	November 1997	Eggers et al.
5695507	December 1997	Auth et al.
5697281	December 1997	Eggers et al.
5697536	December 1997	Eggers et al.
5697882	December 1997	Eggers et al.
5697909	December 1997	Eggers et al.
5700262	December 1997	Acosta et al.
5707352	January 1998	Sekins et al.
5735811	April 1998	Brisken
5741247	April 1998	Rizoiu et al.
5741248	April 1998	Stern et al.
5752965	May 1998	Francis et al.
5755753	May 1998	Knowlton
5782914	July 1998	Schankereli
5785521	July 1998	Rizoiu et al.
5800482	September 1998	Pomeranz et al.
5810764	September 1998	Eggers et al.
5824703	October 1998	Clark, Jr.
5827268	October 1998	Laufer
5836896	November 1998	Rosenschein
5843019	December 1998	Eggers et al.
5843073	December 1998	Sinofsky
5871469	February 1999	Eggers et al.
5879329	March 1999	Ginsburg
5885243	March 1999	Capetan et al.
5888198	March 1999	Eggers et al.
5891095	April 1999	Eggers et al.
5891134	April 1999	Goble et al.
5913856	June 1999	Chia et al.
5938660	August 1999	Swartz et al.
5944686	August 1999	Patterson et al.
5944715	August 1999	Goble et al.
5957919	September 1999	Laufer
5964752	October 1999	Stone
5968037	October 1999	Rizoiu
5980504	November 1999	Sharkey et al.
5986662	November 1999	Argiro et al.
5989212	November 1999	Sussman et al.
5989238	November 1999	Ginsburg
5989249	November 1999	Kirwan
5989445	November 1999	Wise et al.
5997499	December 1999	Sussman et al.
6024095	February 2000	Stanley, III
6024733	February 2000	Eggers et al.
6027501	February 2000	Goble et al.
6032077	February 2000	Pomeranz
6032674	March 2000	Eggers et al.
6047700	April 2000	Eggers et al.
6053909	April 2000	Shadduck
6056746	May 2000	Goble et al.
6059011	May 2000	Giolo
6063079	May 2000	Hovda et al.
6063081	May 2000	Mulier et al.
6066134	May 2000	Eggers et al.
6074358	June 2000	Andrew et al.
6080128	June 2000	Sussman et al.
6080151	June 2000	Swartz et al.
6083255	July 2000	Laufer et al.
6095149	August 2000	Sharkey et al.
6099251	August 2000	LaFleur
6102046	August 2000	Weinstein et al.
6102885	August 2000	Bass
6106516	August 2000	Bmassengill
6110162	August 2000	Sussman et al.
6113722	September 2000	Hoffman et al.
6126682	October 2000	Sharkey et al.
6130671	October 2000	Argiro
6139571	October 2000	Fuller et al.
6149620	November 2000	Baker et al.
6156036	December 2000	Sussman et al.
6159194	December 2000	Eggers et al.
6162232	December 2000	Shadduck
6168594	January 2001	LaFontaine et al.
6174308	January 2001	Goble et al.
6179805	January 2001	Sussman et al.
6190381	February 2001	Olsen et al.
6194066	February 2001	Hoffman
6196989	March 2001	Padget et al.
6200333	March 2001	Laufer
6206848	March 2001	Sussman et al.
6210404	April 2001	Shadduck
6210405	April 2001	Goble et al.
6219059	April 2001	Argiro
6224592	May 2001	Eggers et al.
6231567	May 2001	Rizoiu et al.
6235020	May 2001	Cheng et al.
6238391	May 2001	Olsen et al.
6254597	July 2001	Rizoiu et al.
6261286	July 2001	Goble et al.
6261311	July 2001	Sharkey et al.
6264650	July 2001	Hovda et al.
6264651	July 2001	Underwood et al.
6264654	July 2001	Swartz et al.
6277112	August 2001	Underwood et al.
6283910	September 2001	Bradshaw et al.
6283961	September 2001	Underwood et al.
6283989	September 2001	Laufer et al.
6287274	September 2001	Sussman et al.
6290715	September 2001	Sharkey et al.
6296636	October 2001	Cheng et al.
6296638	October 2001	Davison et al.
6299633	October 2001	Laufer
6300150	October 2001	Venkatasubramanian
6312408	November 2001	Eggers et al.
6312474	November 2001	Francis et al.
6315755	November 2001	Sussman
6319222	November 2001	Andrew et al.
6327505	December 2001	Medhkour et al.
6331171	December 2001	Cohen
6355032	March 2002	Hovda et al.
6375635	April 2002	Moutafis et al.
6379350	April 2002	Sharkey et al.
6391025	May 2002	Weinstein et al.
6394949	May 2002	Crowley et al.
6394996	May 2002	Lawrence et al.
6398759	June 2002	Sussman et al.
6398775	June 2002	Perkins et al.
6409723	June 2002	Edwards
6416508	July 2002	Eggers et al.
6458231	October 2002	Wapner et al.
6461350	October 2002	Underwood et al.
6464694	October 2002	Massengill
6464695	October 2002	Hovda et al.
6468270	October 2002	Hovda et al.
6468274	October 2002	Alleyne et al.
6468313	October 2002	Claeson et al.
6482201	November 2002	Olsen et al.
6482202	November 2002	Goble et al.
6488673	December 2002	Laufer et al.
6493589	December 2002	Medhkour et al.
6500173	December 2002	Underwood et al.
6508816	January 2003	Shadduck
6517568	February 2003	Sharkey et al.
6522930	February 2003	Schaer et al.
6527761	March 2003	Soltesz et al.
6527766	March 2003	Bair
6540741	April 2003	Underwood et al.
6544211	April 2003	Andrew et al.
6544248	April 2003	Bass
6547810	April 2003	Sharkey et al.
6558379	May 2003	Batchelor et al.
6575929	June 2003	Sussman et al.
6575968	June 2003	Eggers et al.
6579270	June 2003	Sussman et al.
6582423	June 2003	Thapliyal et al.
6585639	July 2003	Kotmel et al.
6588613	July 2003	Pechenik et al.
6589201	July 2003	Sussman et al.
6589204	July 2003	Sussman et al.
6592594	July 2003	Rimbaugh et al.
6595990	July 2003	Weinstein et al.
6599311	July 2003	Biggs et al.
6602248	August 2003	Sharps et al.
6605087	August 2003	Swartz et al.
6610043	August 2003	Ingenito
6620130	September 2003	Ginsburg
6620155	September 2003	Underwood et al.
6623444	September 2003	Babaev
6632193	October 2003	Davison et al.
6632220	October 2003	Eggers et al.
6634363	October 2003	Danek et al.
6648847	November 2003	Sussman et al.
6652594	November 2003	Francis et al.
6653525	November 2003	Ingenito et al.
6659106	December 2003	Hovda et al.
6669685	December 2003	Rizoiu et al.
6669694	December 2003	Shadduck
6676628	January 2004	Sussman et al.
6676629	January 2004	Andrew et al.
6679264	January 2004	Deem et al.
6679879	January 2004	Shadduck
6682520	January 2004	Ingenito
6682543	January 2004	Barbut et al.
6692494	February 2004	Cooper et al.
6695839	February 2004	Sharkey et al.
6699212	March 2004	Kadziauskas et al.
6699244	March 2004	Carranza et al.
6712811	March 2004	Underwood et al.
6712812	March 2004	Roschak et al.
6719738	April 2004	Mehier
6719754	April 2004	Underwood et al.
6723064	April 2004	Babaev
6726684	April 2004	Woloszko et al.
6726708	April 2004	Lasheras
6746447	June 2004	Davison et al.
6755794	June 2004	Soukup
6758846	July 2004	Goble et al.
6763836	July 2004	Tasto et al.
6764487	July 2004	Mulier et al.
6766202	July 2004	Underwood et al.
6770070	August 2004	Balbierz
6770071	August 2004	Woloszko et al.
6772012	August 2004	Ricart et al.
6776765	August 2004	Soukup et al.
6780180	August 2004	Goble et al.
6805130	October 2004	Tasto et al.
6813520	November 2004	Truckai et al.
6832996	December 2004	Woloszko et al.
6837884	January 2005	Woloszko
6837888	January 2005	Ciarrocca et al.
6852108	February 2005	Barry et al.
6860847	March 2005	Alferness et al.
6860868	March 2005	Sussman et al.
6875194	April 2005	MacKool
6896674	May 2005	Woloszko et al.
6896675	May 2005	Leung et al.
6901927	June 2005	Deem et al.
6904909	June 2005	Andreas et al.
6907881	June 2005	Suki et al.
6911028	June 2005	Shadduck
6918903	July 2005	Bass
6921385	July 2005	Clements et al.
6929640	August 2005	Underwood et al.
6949096	September 2005	Davison et al.
6955675	October 2005	Jain
6960182	November 2005	Moutafis et al.
6962584	November 2005	Stone et al.
6972014	December 2005	Eum et al.
6978174	December 2005	Gelfand et al.
6986769	January 2006	Nelson et al.
6991028	January 2006	Comeaux et al.
6991631	January 2006	Woloszko et al.
7022088	April 2006	Keast et al.
7031504	April 2006	Argiro et al.
7083612	August 2006	Littrup et al.
7094249	August 2006	Broome et al.
7128748	October 2006	Mooradian et al.
7136064	November 2006	Zuiderveld
7144402	December 2006	Kuester, III
7144588	December 2006	Oray et al.
7162303	January 2007	Levin et al.
7192400	March 2007	Campbell et al.
7233820	June 2007	Gilboa
7235070	June 2007	Vanney
7311708	December 2007	McClurken
7335195	February 2008	Mehier
7347859	March 2008	Garabedian et al.
7524315	April 2009	Blott et al.
7549987	June 2009	Shadduck
7585295	September 2009	Ben-Nun
7617005	November 2009	Demarais et al.
7620451	November 2009	Demarais et al.
7647115	January 2010	Levin et al.
7653438	January 2010	Deem et al.
7674259	March 2010	Shadduck
7717948	May 2010	Demarais et al.
7756583	July 2010	Demarais et al.
7815616	October 2010	Boehringer et al.
7815646	October 2010	Hart
7853333	December 2010	Demarais
7873417	January 2011	Demarais et al.
7892229	February 2011	Shadduck et al.
7937143	May 2011	Demarais et al.
7993323	August 2011	Barry et al.
8016823	September 2011	Shadduck
8131371	March 2012	Demarals et al.
8131372	March 2012	Levin et al.
8145316	March 2012	Deem et al.
8145317	March 2012	Demarais et al.
8150518	April 2012	Levin et al.
8150519	April 2012	Demarais et al.
8150520	April 2012	Demarais et al.
8175711	May 2012	Demarais et al.
8187269	May 2012	Shadduck et al.
8313485	November 2012	Shadduck
8444636	May 2013	Shadduck et al.
8574226	November 2013	Shadduck
8579888	November 2013	Hoey et al.
8579892	November 2013	Hoey et al.
8579893	November 2013	Hoey
2001/0020167	September 2001	Woloszko et al.
2001/0029370	October 2001	Hodva et al.
2001/0037106	November 2001	Shadduck
2002/0049438	April 2002	Sharkey et al.
2002/0077516	June 2002	Flanigan
2002/0078956	June 2002	Sharpe et al.
2002/0082667	June 2002	Shadduck
2002/0095152	July 2002	Ciarrocca et al.
2002/0111386	August 2002	Sekins et al.
2002/0128638	September 2002	Chauvet et al.
2002/0133147	September 2002	Marchitto et al.
2002/0161326	October 2002	Sussman et al.
2002/0177846	November 2002	Mulier et al.
2002/0193789	December 2002	Underwood et al.
2003/0028189	February 2003	Woloszko et al.
2003/0040742	February 2003	Underwood et al.
2003/0097126	May 2003	Woloszko et al.
2003/0099279	May 2003	Venkatasubramanian et al.
2003/0109869	June 2003	Shadduck
2003/0130655	July 2003	Woloszko et al.
2003/0130738	July 2003	Hovda et al.
2003/0144654	July 2003	Hilal
2003/0158545	August 2003	Hovda et al.
2003/0163178	August 2003	Davison et al.
2003/0181922	September 2003	Alferness
2003/0212394	November 2003	Pearson et al.
2003/0212395	November 2003	Woloszko et al.
2003/0225364	December 2003	Kraft et al.
2004/0024398	February 2004	Hovda et al.
2004/0024399	February 2004	Sharps et al.
2004/0031494	February 2004	Danek et al.
2004/0038868	February 2004	Ingenito
2004/0047855	March 2004	Ingenito
2004/0049180	March 2004	Sharps et al.
2004/0054366	March 2004	Davison et al.
2004/0055606	March 2004	Hendricksen et al.
2004/0068256	April 2004	Rizoiu et al.
2004/0068306	April 2004	Shadduck
2004/0087937	May 2004	Eggers et al.
2004/0116922	June 2004	Hovda et al.
2004/0193150	September 2004	Sharkey et al.
2004/0199226	October 2004	Shadduck
2004/0230190	November 2004	Dahla et al.
2004/0254532	December 2004	Mehier
2005/0004634	January 2005	Ricart et al.
2005/0010205	January 2005	Hovda et al.
2005/0070894	March 2005	McClurken
2005/0119650	June 2005	Sanders et al.
2005/0166925	August 2005	Wilson et al.
2005/0171582	August 2005	Matlock
2005/0187543	August 2005	Underwood et al.
2005/0215991	September 2005	Altman et al.
2005/0222485	October 2005	Shaw et al.
2005/0228423	October 2005	Khashayar et al.
2005/0228424	October 2005	Khashayar et al.
2005/0240171	October 2005	Forrest
2005/0267467	December 2005	Paul et al.
2005/0283143	December 2005	Rizoiu
2006/0004400	January 2006	McGurk et al.
2006/0047291	March 2006	Barry
2006/0085054	April 2006	Zikorus et al.
2006/0100619	May 2006	McClurken et al.
2006/0130830	June 2006	Barry
2006/0135955	June 2006	Shadduck
2006/0142783	June 2006	Lewis et al.
2006/0161233	July 2006	Barry et al.
2006/0200076	September 2006	Gonzalez et al.
2006/0206150	September 2006	Demarais et al.
2006/0224154	October 2006	Shadduck et al.
2006/0271111	November 2006	Demarais et al.
2007/0032785	February 2007	Diederich et al.
2007/0036417	February 2007	Argiro et al.
2007/0091087	April 2007	Zuiderveld
2007/0129720	June 2007	Demarais et al.
2007/0129760	June 2007	Demarais et al.
2007/0129761	June 2007	Demarais et al.
2007/0135875	June 2007	Demarais et al.
2007/0265687	November 2007	Deem et al.
2008/0033493	February 2008	Deckman et al.
2008/0097429	April 2008	McClurken
2008/0103566	May 2008	Mehier
2008/0110457	May 2008	Barry et al.
2008/0114297	May 2008	Barry et al.
2008/0125747	May 2008	Prokop
2008/0132826	June 2008	Shadduck et al.
2008/0213331	September 2008	Gelfand et al.
2008/0255642	October 2008	Zarins et al.
2009/0036948	February 2009	Levin et al.
2009/0054871	February 2009	Sharkey et al.
2009/0062873	March 2009	Wu et al.
2009/0076409	March 2009	Wu et al.
2009/0105702	April 2009	Shadduck
2009/0105703	April 2009	Shadduck
2009/0125009	May 2009	Zikorus et al.
2009/0149846	June 2009	Hoey et al.
2009/0216220	August 2009	Hoey et al.
2009/0306640	December 2009	Glaze et al.
2009/0312753	December 2009	Shadduck
2010/0076416	March 2010	Hoey et al.
2010/0094270	April 2010	Sharma
2010/0114083	May 2010	Sharma
2010/0137860	June 2010	Demarais et al.
2010/0137952	June 2010	Demarais et al.
2010/0160905	June 2010	Shadduck
2010/0168731	July 2010	Wu et al.
2010/0168739	July 2010	Wu et al.
2010/0174282	July 2010	Demarais et al.
2010/0179528	July 2010	Shadduck et al.
2010/0185189	July 2010	Hoey
2010/0191112	July 2010	Demarais et al.
2010/0204688	August 2010	Hoey et al.
2010/0222851	September 2010	Deem et al.
2010/0222854	September 2010	Demarais et al.
2010/0249773	September 2010	Clark et al.
2010/0262133	October 2010	Hoey et al.
2010/0268307	October 2010	Demarais et al.
2011/0060324	March 2011	Wu et al.
2011/0077628	March 2011	Hoey et al.
2011/0112400	May 2011	Emery et al.
2011/0160648	June 2011	Hoey
2011/0264090	October 2011	Shadduck et al.
2012/0065632	March 2012	Shadduck

Foreign Patent Documents


WO 00/11927	Mar 2000	WO
WO 00/29055	May 2000	WO
WO 03/070302	May 2000	WO
WO 02/069821	Sep 2002	WO
WO 03/086498	Oct 2003	WO
WO 2005/025635	Mar 2005	WO
WO 2005/102175	Nov 2005	WO
WO 2006/003665	Jan 2006	WO
WO 2006/055695	May 2006	WO
WO 2009/009398	Jan 2009	WO

Other References

Coda, et al., "Effects of pulmonary reventilation on gas exchange after cryolytic disobstruction of endobronchial tumors," Minerva Medical, vol. 72, pp. 1627-1631, Jun. 1981 (with English translation). cited by applicant .
Fishman et al., "A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema," N Engl J Med, vol. 348, No. 21, pp. 2059-2073, May 22, 2003. cited by applicant .
Homasson, et al., "Bronchoscopic cryotherapy for airway strictures caused by tumors," Chest, vol. 90, No. 2, pp, 159-164, Aug. 1986. cited by applicant .
Li, K., "Efficient optimal net surface detection for image segmentation--from theory to practice," M.Sc. Thesis, The University of Iowa, 2003. cited by applicant .
Marasso, et al., "Cryosurgery in bronchoscopic treatment of tracheobronchial stenosis," Chest, vol. 103, No. 2, pp. 472-474, Feb. 1993. cited by applicant .
Marasso, et al., "Radiofrequency resection of bronchial tumours in combination with cryotherapy: evaluation of a new technique," Thorax, vol. 53, pp. 106-109, 1998. cited by applicant .
Mathur et al., "Fiberoptic bronchoscopic cryotherapy in the management of tracheobronchial obstruction," Chest, vol. 110, No. 3, pp. 718-723, Sep. 1996. cited by applicant .
Morice et al. "Endobrinchial argon plasma coagulation for treatment of hemotysis and neoplastic airway obstruction," Chest, vol. 119, No. 3, pp. 781-787, Mar. 2001. cited by applicant .
Moulding et al., "Preliminary studies for achieving transcervical oviduct occlusion by hot water or low-pressure steam," Advancesin Planned Parenthood, vol. 12, No. 2, pp. 79-85, 1977. cited by applicant .
Quin, J., "Use of neodymium yttrium aluminum garnet laser in long-term palliation of airway obstruction," Connecticut Medicine, vol. 59, No. 7, pp. 407-412, Jul. 1995. cited by applicant .
Sutedja, et al., "Bronchoscopic treatment of lung tumors," Elsevier, Lung Cancer, 11, pp. 1-17, 1994. cited by applicant .
Tschirren et al.; "Intrathoracic airway trees: segmentation and airway morphology analysis from low-dose CT scans;" IEEE Trans. Med. Imaging, vol. 24, No. 12; pp. 1529-1539, Dec. 2005. cited by applicant .
Tschirren, J., "Segmentation, anatomical labeling, branchpoint matching, and quantitative analysis of human airway trees in volumetric CT images," Ph.D. Thesis, The University of Iowa, 231 pages, Aug. 2003. cited by applicant .
Tschirren, J., "Segmentation, anatomical labeling, branchpoint matching, and quantitative analysis of human airway trees in volumetric CT images," Slides from Ph.D. defense, University of Iowa, 130 pages, Aug. 2003. cited by applicant .
Unger, M. et al. "Monolithic Microfabricated Valves and Pumps by Multilayer Soft Lithography," Science, vol. 288, pp. 113-116, Apr. 7, 2000, accessed at http://web.mit.edu/thorsen/www/113.pdf. cited by applicant .
Xia, Y. et al. "Soft Lithography," Annu. Rev. Mater. Sci., vol. 28, pp. 153-184, 1998, accessed at http://www.bwfoundry.com/xia.pdf. cited by applicant.

Primary Examiner: Dvorak; Linda
Assistant Examiner: Scott; Amanda
Attorney, Agent or Firm: Levine Bagade Han LLP

Claims

What is claimed is:

1. A method of treating tissue, the comprising: positioning a probe working end in an interface with tissue; ejecting a high pressure flow of flow media from a working end outlet, wherein the flow comprises at least in a part a condensable vapor, and wherein the flow has a selected pressure and velocity that disintegrates tissue; and controllably rotating the working end at a selected speed to control the depth of disintegration of tissue proximate the outlet.

2. The method of claim 1 wherein the high pressure flow is jetted from a plurality of outlets at or along the working end.

3. The method of claim 1 wherein the flow media is selected from the group of water vapor, atomized water droplets, water and a pharmacological agent.

4. The method of claim 1 wherein the working end is rotated so that tissue is disintegrated to a depth of less than 1 mm for each 360.degree. revolution of the outlet.

5. The method of claim 1 wherein the working end is rotated so that tissue is disintegrated to a depth of less than 0.5 mm for each 360.degree. revolution of the outlet.

6. The method of claim 1 wherein the working end is rotated at a rate so that tissue is disintegrated to a depth of less than 0.1 mm for each 360.degree. revolution of the outlet.

7. The method of claim 1 wherein the working end is rotated at a rate so that tissue is disintegrated to a depth of less than 1 mm for each 360.degree. revolution of the outlet.

8. The method of claim 1 wherein the working end is rotated at a rate so that tissue is disintegrated to a depth of less than 0.5 mm for each 360.degree. revolution of the outlet.

9. The method of claim 1 wherein the working end is rotated at a rate so that tissue is disintegrated to a depth of less than 0.1 mm for each 360.degree. revolution of the outlet.

10. The method of claim 1 wherein the working; end is rotated between a rate of 10 rpm to 10,000 rpm.

11. The method of claim 1 further comprising removing disintegrated tissue through an aspiration port communicating with an aspiration channel in the probe.

12. The method of claim 1 wherein the condensable vapor applies heat to seal tissue.

13. The method of claim 1 wherein the working end has a longitudinal axis and flow media is ejected at an angle relative to the axis.

14. A method of tissue ablation, comprising: positioning a probe working end in an interface with a tissue volume containing first and second tissue types; ejecting at least one high pressure flow of flow media from the probe working end, wherein a flow comprises at least in a part a condensable vapor that applies energy capable of sealing tissue, wherein the flow has a selected pressure and velocity that applies energy that discriminates disintegration of tissue between the first and second tissue types, moving the working end axially and/or rotationally contemporaneous with ejecting flow media; and removing disintegrated tissue through an aspiration port communicating with an aspiration channel in the probe.

15. The method of claim 14 wherein at least two flow of different flow media are ejected from the working end.

16. The method of claim 15 wherein different flow media are selected from the group of water vapor, atomized water droplets, water and a pharmacological agent.

17. The method of claim 14 wherein the flow media is ejected from a plurality of outlets in the working end.

18. The method of claim 14 wherein the flow media is ejected from at least one outlet that is recessed within, the aspiration port.

19. The method of claim 14 wherein the flow media is pulsed.

20. The method of claim 14 wherein a computer controller and motor controllably moves the working end.

21. The method of claim 14 wherein a computer controller controls parameters of the ejection of flow media.

22. The method of claim 14 further comprising imaging the flow of flow media.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a non-provisional of U.S. Patent Application No. 61/259,097 filed on Nov. 6, 2009, the content of which is incorporated herein by reference in its entirety.

The systems and methods described herein are also related to: U.S. Patent Provisional Application No. 61/126,647 filed May 6, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/126,651 filed May 6, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; U.S. Application No. 61/126,612 filed May 6, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/126,636 filed May 6, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/130,345 filed May 31, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/191,459 filed Sep. 9, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/066,396 filed Feb. 20, 2008 entitled TISSUE ABLATION SYSTEM AND METHOD OF USE; Application No. 61/123,416 filed Apr. 8, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/068,049 filed Mar. 4, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/123,384 filed Apr. 8, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/068,130 filed Mar. 4, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/123,417 filed Apr. 8, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/123,412 filed Apr. 8, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/126,830 filed May 7, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; and Application No. 61/126,620 filed May 6, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE.

The systems and methods described herein are also related to U.S. patent application Ser. No. 10/681,625 filed Oct. 7, 2003 entitled MEDICAL INSTRUMENTS AND TECHNIQUES FOR THERMALLY-MEDIATED THERAPIES; application Ser. No. 11/158,930 filed Jun. 22, 2005 entitled MEDICAL INSTRUMENTS AND TECHNIQUES FOR TREATING PULMONARY DISORDERS; application Ser. No. 11/244,329 filed Oct. 5, 2005 entitled MEDICAL INSTRUMENTS AND METHODS OF USE and application Ser. No. 11/329,381 filed Jan. 10, 2006 entitled MEDICAL INSTRUMENT AND METHOD OF USE.

All of the applications discussed throughout this disclosure are incorporated herein by this reference and made a part of this specification, together with the specifications of all other commonly-invented applications cited in the above applications.

FIELD OF THE INVENTION

This invention relates to medical instruments and systems for applying energy to tissue. Variations of the systems and methods described herein include ablating, sealing, and extracting tissue with high pressure flows of fluids that in part utilizes a vapor-to-liquid phase change of flow media to apply thermal energy to the tissue.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a tissue ablation system corresponding to the invention that utilizes high pressure flows of a flow media delivered into tissue from the working end of a probe to allow the controlled ablation of targeted tissue, and aspiration of ablated tissue.

FIG. 2 is a handle component of the ablation system of FIG. 1.

FIG. 3 is a schematic a schematic representation of an inductive heater component of the ablation system of FIG. 1 that is configured to convert a flow of liquid flow media into a flow of vapor and fluid droplets for jetting from the working end of the probe.

FIG. 4A is a cut-away view of the extension member of the ablation probe of FIG. 1.

FIG. 4B is a perspective view of the working end of the ablation probe of FIG. 1.

FIG. 5 is a schematic representation of a spinal disc showing the ablation probe and working end of FIG. 4B following insertion of the working end into the nucleus, and its movement to ablate and extract the gelatinous nucleus without ablating the annulus.

FIG. 6A is a perspective view of an alternative working end of an ablation probe similar to that of FIGS. 4A and 4B with flow outlets in an angled tissue-contacting surface and aspiration port, the flow outlets having converging axes for jetting flow media to ablate tissue.

FIG. 6B is a sectional view of the working end of FIG. 6A taken along line 6B-6B of FIG. 6A showing the axes of the flow outlets coupled to first and second sources of different flow media.

FIG. 7 is a perspective view of an alternative working end of an ablation probe similar to that of FIGS. 6A-6B with a laterally-facing tissue-ablating surface, with the aspiration port and flow media outlets having outwardly directed axes for jetting flow media to ablate tissue.

FIG. 8 is a perspective view of an alternative working end similar to that of FIG. 7 with a sharp distal comprising an RF electrode for abating tissue.

FIG. 9 is a perspective view of another working end similar to that of FIGS. 7 and 8 with extendable-retractable sharp distal for penetrating tissue.

FIG. 10 is a perspective view of another working end similar to that of FIGS. 4A and 7 with concentric first and second flow outlets supported in a centrally position in an aspiration port together with a loop member for scraping tissue.

FIG. 11 is a perspective view of another working end similar to that of FIG. 10 with concentric first and second flow outlets with a surrounding aspiration port together with a plurality of brush elements for brushing tissue.

FIG. 12 is a perspective view of another working end with an elongated aspiration port in a knife-like edge and surrounding flow media outlets.

FIG. 13A is a representational view of another working end that is moveable axially and rotationally with multiple outlets for jetting flow media to cut, ablate disintegrate and remove tissue, with the figure showing rotational movement and cutting paths.

FIG. 13B is another view of the working end of FIG. 13A showing axial movement and cutting paths.

DETAILED DESCRIPTION

FIGS. 1 and 2 depict an embodiment corresponding to the invention that provides an ablation system 100 that utilizes controlled high pressure flows of a flow media to ablate, disintegrate, seal and optionally remove tissue from a patient's body. FIG. 1 shows an ablation probe 105 that is configured with a pistol-grip handle member 106 for gripping with a human hand. The handle member 106 alternatively can be any in-line handle or other type of handle, or any proximal handle end adapted for connection to a surgical robot. In one embodiment shown in FIGS. 1 and 2, the handle comprises first and second detachable components, 108A and 108B. Handle component 108A is coupled to an elongated extension member 110 extending along a longitudinal axis 115 to a distal working end 120. The axial extension member 110 can have a suitable length and diameter for a particular ablation procedure, and can range from 1 mm to 10 mm in cross section and can be rigid, semi-rigid, deflectable, hinged or deformable. The extension member 110 also can be configured for with a channel for accommodating a rigid or flexible endoscope or a disposable optic fiber to provide viewing means for navigating the working end in the interior of a patient's body. As will be described below, the system is configured to deliver at least one flow of a flow media, such as water vapor, atomized water droplets or a jet of water in a pulsed or continuous mode, any of which can be configured to ablate tissue. The use of water vapor and fluid jets to ablate tissue has been described in the following co-pending U.S. patent applications: U.S. patent application Ser. No. 10/681,625 filed Oct. 7, 2003 titled "Medical Instruments and Techniques for Thermally-Mediated Therapies"; Ser. No. 11/158,930 filed Jun. 22, 2005 titled "Medical Instruments and Techniques for Treating Pulmonary Disorders"; Ser. No. 11/244,329 filed Oct. 5, 2005 titled "Medical Instruments and Methods of Use" and Ser. No. 11/329,381 filed Jan. 10, 2006 titled "Medical Instrument and Method of Use". All of the above applications are incorporated herein by this reference and made a part of this specification, together with the specifications of all other commonly-invented applications cited in the above applications.

The generation and delivery of a collapsible, high energy vapor for various therapeutic procedures is further disclosed in systems with remote vapor generation systems or sources in co-pending applications 60/929,632, 61/066,396, 61/068,049, or with vapor generator in a handle or working end, or combination thereof, as described in applications 61/068,130, 61/123,384, 61/123,412, 61/126,651, 61/126,612, 61/126,636, 61/126,620 all of which are incorporated herein by reference in their entirely.

FIGS. 1 and 2 illustrate an embodiment of tissue ablation system 100 in which detachable handle component 108B carries a heat applicator system for converting a fluid flow to a vapor flow which comprises an inductive heater assembly 124 operatively coupled to an electrical source such as an RF generator 125. The inductive heater 124 is adapted for converting a pressurized flow of a liquid, such as water or saline, into a flow of water vapor, or a pulsed flow of water vapor, atomized water droplets and/or a flow of water. The inductive heater 124 can be as described in U.S. Provisional patent application Ser. No. 12/389,808 incorporated by reference herein. In FIG. 2, it can be seen that a pressurized flow media source 140 contains the fluid or flow media 150 such as water or saline. The source 140 delivers the flow media through flexible conduit 142 and cooperating fittings 144A and 144B to handle component 108B and to inductive heater 124 (FIGS. 2 and 3). The pressurized fluid source 140 and computer controller 155 is adapted to deliver the flow media 150 at a controlled flow rate and pressure through a flow channel 160 into the inductive heater 124 and through flow channel 162 out of the inductive heater into at least one cooperating flow channel 166 in extension member 110 that communicates with at least one flow outlet 170 in the working end 120 (FIGS. 4A-4B). The flow rate of media into the inductive heater 124 can range from 0.01 ml/min to 20 ml/min and provides at pressures of between 10 psi and 10,000 psi.

As can be seen in FIGS. 2 and 3, the flow of liquid flow media 150 is directed through the inductive heater 124 that is housed in handle component 108B. The handle 106 can comprise a molded shell of a plastic and can provide an air gap or insulation 172 around the inductive heater 124. In one embodiment (FIG. 3), the inductive heater 124 comprises a ceramic cylinder 174 about 1.0'' to 1.5'' in length and 0.25'' in diameter with a 0.10'' bore 176 therein. The bore 176 contains an inductively heatable structure with a plurality of axial microchannels for receiving fluid flows which in one embodiment can be provided by a tightly-packed assembly of small diameter microtubes 177. The microtubes 177 can be any suitable material, for example any stainless steel (e.g., 316 SS) that can be instantly heated by induction. In one embodiment, the stainless steel microtubes 177 are 0.016'' thin wall tubes. A winding 180 of one to ten layers having with the winding having an axial length of 1.0'' is provided about the cylinder 172 for inductive heating of microtubes 177 using very high frequency current from electrical source 125. In one embodiment the winding 180 can be 26 Ga. Copper wire with a Teflon coating. It has been found that delivering at least 50 W, 100 W, 200 W, 300 W, or 400 W with suitable flow rates of water through the channels in and around the microtubes 177 can produce very high quality water vapor, for example 95% vapor or higher. An insulation layer 172 is provided about an exterior of the inductive heater, as depicted in phantom view in FIG. 3. The insulation can comprise an air or partial vacuum gap, an aerogel, insulating glass or ceramic microspheres or another insulator material. In general, the inductive heater 124 and controller 155 can be configured to produce a high quality vapor with precise parameters in terms of vapor quality, exit vapor pressure from the working end 120 and exit vapor temperature, together with maintaining the parameters within a tight range over a treatment interval. All these parameters can be controlled with a high level of precision to achieve controlled dosimetry, no matter whether a particular tissue ablation treatment calls for (i) very low pressures in tissue (e.g., 0.1 to 5 psi) over a treatment interval or (ii) very high pressures (50 psi or greater) and no matter whether the treatment interval is in the 1-10 second range or 2 to 5 minute range.

In some tissue ablation procedures, it has been found that introducing and navigating the extension member 110 and working end 120 is best accomplished by gripping handle component 108A without the laterally extending handle component 108B. The physician can also maneuver the probe 105 more easily without the additional weight and bulk of handle component 108B. For this reason, an embodiment of probe 105 can provide detachable handle components 108A and 108B. FIGS. 1 and 2, it can be seen that handle component 108B is detachably coupled to handle component 108A by first and second projecting grip-tab elements 184a and 184b that are configured to project into receiving slots in handle component 108A. Push-buttons 186a and 186b in handle 108B can be depressed to release the handle components 108A and 108B from one another. Alignment pins 188 in handle component 108B cooperate with receiving bores in handle component 108A to align the handle components when being attached to on another.

Referring to FIG. 2, a tubular projecting element 190 with flow channel 165 therein extends outwardly from handle component 108B and is configured for a fluid-tight fit in a cooperating fitting (not shown) in handle component 108A. One or more o-rings can be used to provide a fluid-tight seal around element 190 or the flow channel 165 that extends to the working end 120.

In one embodiment depicted in FIGS. 1 and 2, a second pressurized source 200 of a second flow media 205 is coupled to a flow channel in conduit 142 and to a second flow channel 210 in handle component 108B that extends from fittings 144A and 144B to a second tubular projecting element 220 that extends outwardly from handle component 108B similar to projecting element 190. The second projecting element 220 and channel 210 therein are configured for a fluid-tight fit to a cooperating fitting and flow channel 222 in handle component 108A (not shown) that can extends through extension member 110 to working end 120 as shown in one embodiment in FIGS. 6A-6B. As can be seen in FIG. 2. the second flow media source 200 bypasses the inductive heater 124 and can deliver a flow of a gas or liquid to the working end 120 for one or more purposes, with the a continuous or pulsed flow optionally controlled by controller 155. In an embodiment, the second flow media can comprise a pharmacologic agent that is delivered to tissue from a dedicated outlet in the working end or the agent can be mixed with the heated flow media in the extension member 110 or working end 120. In another embodiment, the second flow media 205 can comprise a high pressure fluid flow that is adapted for ejection or jetting from a dedicated outlet in the working end to disintegrate tissue, or the flow can be jetted out of at least one outlet 170 (FIG. 4B) that delivers the first flow media 150. In another embodiment, the second flow media 205 can comprise a flow of gas that is adapted mixing with the heated flow media to lower its mass average temperature. In another embodiment, the second flow media can comprise a cooling gas or liquid for cooling targeted tissue or adjacent tissue after or during after an ablative treatment.

Referring to FIGS. 1, 4A and 4B, the system 100 further includes a negative pressure source 240 also controlled by controller 155 for optionally applying aspiration forces through an aspiration channel 244 in extension member 110 that extends to at least one open aspiration port 245 in the working end 120 (FIG. 4B). The negative pressure source 240 can be connected to a valved port 248 in handle component 108A that communicates with the aspiration channel 244 (FIG. 1).

Referring to FIGS. 4A-4B, it can be seen that an embodiment of working end 120 comprises a plurality of flow outlets 170 spaced apart and positioned around an open aspiration port 245. In one embodiment, a plurality of flow channels 166 in extension member 110 carry the flow media 150 to the working end 120 but a single channel can branch to the outlets or an annular channel can communicate with outlets 170. The aspiration port 245 and aspiration channel 244 are as large as possible in relation to the cross-section of extension member 110, to maximize aspiration forces at the port 245. The extension member 110 can have a cross section ranging from about 1 mm to 10 mm for various tissue ablation applications. The aspiration port 245 can be singular or plural, and can be round, oval, elongated or comprise one or more narrow slits along a blade-like edge. In The working end has a surface 250 surrounding the aspiration port 245 that is configured for contacting tissue or moving over tissue targeted for ablation. The flow outlets 170 can be disposed in surface 250 or in a recessed surface 252 that extends around port 245 that is angled or beveled relative to surface 250. The plane P of surface 250 and port 245 is 90.degree. relative to axis 115 in the embodiment of FIGS. 4A-4B, but the angle of the plane of port 245 can be angled relative to axis 115 or parallel and offset from axis 115 as will be described below (see FIGS. 6A-6B). The flow outlets can range in number from 2 to 40 or more, and in the embodiment of FIGS. 4A-4B comprises four outlets 170. The axis 260 of media flows jetted from the flow outlets can be aligned with axis 115 or any other angle that is angled inward toward axis 115 or retrograde relative to axis 115. The flow outlets 170 range in diameter from about 0.0005 inches to 0.020 inches.

In use, the inductive heater 124 is configured to apply energy to a flow of flow media 150 to convert the media to vapor. The flow media may be provided at pressures ranging from 1 psi to 1000 psi and flow rates described above, in either a continuous flow or pulsed flows. In a method corresponding to the invention, the media flows from outlets 170 can have a predetermined vapor quality. For example when the flow media 150 is water, the vapor media may range from about 50% to 99% water vapor with the non-vapor portion comprising water droplets. By controlling the inflow pressure and flow rate from source 140, the applied energy from heater 124, the number and cross-section of outlets 170, it is possible to control the water vapor component and the water droplet component of flows jetted or ejected from outlets 170 to optimize the jetted flow media for a ablation of a particular tissue. The vapor component of the jetted media condenses to apply thermal energy to targeted tissue which will cause thermal damage, weakening and denaturation of proteins and tissue constituents. At the same time the water droplet component can apply sufficient mechanical forces to disintegrate and volumetrically remove tissue at the flow media-tissue interface. Thus, in one aspect of the invention, the quality of the vapor, i.e., the combination of jetted vapor with jetted water droplets, is configured for cutting the thermally weakened tissue while the aspiration forces through port 245 extracts and removes the tissue. By controlling the vapor quality and jetting pressure or velocity as described above, the thermal and mechanical energy applied to tissue can be modulated to discriminate between or non-ablation or tissues within a targeted tissue volume. In one method, an ablation system can be designed for treating spinal discs to ablate and extract a disc nucleus. The vapor quality and jetting velocity is controlled to discriminate between ablation of a disc nucleus and annulus. In another method, a small diameter probe can select a particular vapor quality and jetting velocity for cutting soft brain tissue without damaging microvasculature. Various neurosurgeries require cutting brain tissue without damage to tougher, elastic vasculature. In another method, a probe can use a selected vapor quality and jetting velocity for cutting any soft tissue without damaging elastic vasculature.

Referring to FIG. 5, one embodiment of system 100 is shown for use in ablating tissue in a nucleus 300 of disc 302. In various procedures to replace a disc nucleus with and artificial nucleus, or in disc decompression procedure or in a fusion procedure, it is desirable to use a tool to ablate and remove a nucleus 300 without damaging the disc annulus 310. Since the procedure is best accomplished with a small diameter probe without viewing means for viewing the targeted tissue, a probe with tissue-discrimination capabilities is needed. In the systems described above, a working end 120 as depicted in FIGS. 4B and 5 can be provided with operating parameters configured that ablate and remove the soft nucleus tissue 300 to thereby create space 308 wherein the operating parameters are not capable of ablating or cutting the disc annulus 310. In other words, the thermal energy provided by the flow and mechanical energy applied by the velocity of water or water droplets imparts energy to disintegrate soft nucleus tissue but does not impart enough energy to disintegrate tougher annulus tissue. In an embodiment configured for disc nucleus ablation, the probe extension member 110 can have a straight axis, slightly curved axis, or articulating working end and can be moved axially, angled and rotated to ablate and extract the disc nucleus as indicated schematically in FIG. 5. Minimally invasive percutaneous access to the disc is known in the art, and can use an access cannula (not shown). As will be described below, the working end 120 can have the outlets 107 and an aspiration port 245 with an distal-facing orientation, an angled orientation or a side-facing orientation.

FIGS. 6A and 6B are perspective and cross-section views of an alternative working end 120 of an ablation probe similar to that FIGS. 1, 4A and 4B, showing an central aspiration channel 244 and port 245 surrounded by an angled distal surface 250 that is angled relative to axis 115. The plane P of surface 250 and port 245 can range from about 30.degree. to 90.degree. relative to axis 115 (FIG. 6B). In this embodiment, the surface 250 is angled and configured for contacting tissue or moving over tissue targeted for ablation. In one embodiment shown in FIGS. 6A-6B, the probe extension member 110 and working end 120 are configured to eject first and second flows of flow media 150 and 205 from first flow media source 140 and second flow media source 200, respectively, to impart energy to disintegrate tissue. In the embodiment of FIGS. 6A-6B, a plurality of flow outlets 170a-170d are disposed in surface in recessed surface 252 that extends around port 245. The flow outlets 170a-170d in surface 252 can have converging axes, (e.g., axes 315a and 315b) which can be at various angles relative to surface 250 and axis 115 of the probe. As can be seen in the FIG. 6B, the flow channels 166 can have a tapered or step-region 316 that reduces the channel cross-section to a small diameter nozzle portion indicated at 318. The working end 120 of FIGS. 6A-6B can be used as shown in FIG. 5, wherein the working end can translated axially and rotated to ablate tissue both distally and to the side of working end 120. The distal tip 318 of the working end can be blunt, sharp, abrasive or serrated. In one embodiment depicted in FIGS. 6A-6B, the flow media 150 from first flow media source 140 is jetted from ports 170a-170c and can comprise a water vapor 150 produced by inductive heater 124, with the vapor media configured to condense and apply thermal energy to tissue, for reasons described above, such a weakening bonds in tissue to allow the mechanical force of jetted fluid flow 205 to more easily disintegrate tissue. The second flow media 205 can be a high pressure fluid jet that is ejected from outlet 170d and is configured to disintegrate or cut tissue.

FIG. 7 is a perspective representation of an alternative working end 120 of an ablation probe that has flow media jetting features similar to that of FIGS. 6A and 6B. The working end 120 of FIG. 7 has a laterally-facing aspiration port 245 surrounded by angled surface 252 in plane P with the working end again configured with at least one flow outlet or a plurality of flow outlets 170a-170d as shown in FIG. 7. Further, the tissue-ablating surface 320 comprising the aspiration port 245 and flow outlets 170a-170d is within a motor-driven inner rotatable sleeve 325 that rotates relative to a non-rotatable outer concentric sleeve 330 that is coupled to a proximal handle. The distal end 332 of the inner sleeve 325 is shown as being blunt, but can also be a sharp penetrating tip. The inner sleeve can be rotated my any motor drive 335, such as an electric motor or air motor at speeds ranging from 10 rpm to 10,000 rpm and can be controlled by controller 155 to rotate in a continuous mode, an oscillating mode or any other continuous, pulsed or intermittent modes. In the embodiment of FIG. 7, the working end is again coupled to first and second flow media sources, 140 and 200 in communication with outlets 170a-170d for ablating tissue. The working end can have one or more flow outlets within any surface 250 or 252 of the working end in the plane P of the aspiration port 245 or inward a distance D of from 0 mm to about 5 mm from plane P.

FIG. 8 is a perspective representation of an alternative working end 120 similar to that of FIGS. 6A and 7. The working end 120 of FIG. 8 can be rotatable by a motor drive or manually moved. The working end 120 of FIG. 8 further comprises a distal tip that comprises at least one RF electrode 340 for ablating tissue. In FIG. 8, the electrode 340 is a monopolar electrode that cooperates with a ground pad or return electrode on extension member 110. The distal electrode 340 can be actuated to assist in navigating or advancing the tip through tissue in the interior of a patient's body prior to using the flow media to ablate and extract tissue. The electrode 340 is operatively connected to a medical RF generator as in known in the art (not shown). In all other respects, the working end 120 of FIG. 8 would function as described previously.

FIG. 9 is another working end 120 similar to that of FIGS. 6A, 7 and 8 that includes an extendable-retractable member 350 with sharp tip 352 for penetrating tissue in the interior of a patient's body, for example, to reach the tissue targeted for ablation with the high pressure flow media of the invention. In all other respects, the working end 120 of FIG. 8 would function as described previously.

FIG. 10 is a perspective representation of another working end 120 of an ablation probe that is similar to that of FIGS. 4A-4B. In the embodiment of FIG. 10, the extension member 110 and working end 120 is coupled to first and second flow media sources, 140 and 200 in communication concentric flow channels nested outer and inner hypotubes 360 and 362 that are supported within the central portion of aspiration channel 244. The first flow media 150 can comprise a condensable vapor media for delivering thermal energy to tissue and is jetted from annular flow channel 355a and flow outlet 370a of the assembly of hypotubes 360 and 362. That is, the flow channel 355a comprises the annular lumen between outer surface of inner hypotube 362 and the inner surface of the bore of the outer hypotube 360. The second flow media 205 can comprise a fluid jet such as water for disintegrating tissue as described above, with the second media 205 jetted flow channel 355b and outlet 370b in the distal end of inner hypotube 362. The distal end of the assembly of hypotubes 360 and 362 can be positioned inward from plane P of surface 250 a distance of 0 mm to about 5 mm. The working end of the FIG. 10 also includes an optional loop member 380 that extends across the aspiration port 245 and can be used to rotate against tissue during an ablation treatment to scrape and apply additional mechanical force against tissue to be extracted. The working end of FIG. 10 further can be motor driven as the embodiment of FIG. 7 (not shown) to thus function as a device to core tissue. The loop member 380 of FIG. 10 also can comprise an extendible member that can extend from about 0 mm to 10 mm from surface 250. It also should be appreciated that all the features of the working end 120 of FIG. 10 can be configured in an angled or side-facing tissue-ablation surface as in the embodiments of FIGS. 6A and 7.

FIG. 11 is another working end 120 similar to that of FIG. 10 that includes brush elements 390 that can number from 1 to 20 that can be a flexible or substantially rigid metal or plastic and can be used for brushing tissue and can be useful in ablation and discrimination of softer and denser tissues. The brushes 390 can also be extendable and retractable in channels 392 in the working end by operation of an actuator in a handle end of the probe.

FIG. 12 is a perspective representation of an alternative working end 120 similar to those previously described that can be used as an ablative knife edge 398 to cut and coagulate tissue, for example, for use in cutting liver tissue in a liver resection procedure. The extension member 110 and working end 120 can be coupled to only a first flow media source or both first and second flow media sources, 140 and 200, as shown in FIG. 12. The first flow media source 140 can comprise a source of a condensable vapor media for delivering thermal energy to tissue that is jetted from outlets 170 (collectively) on one side of elongate aspiration port 245. The second flow media source 200 can comprise a source of a fluid that is jetted from outlets 170' (collectively) on the opposing side of aspiration port 245. The outlets 170 and 170' can range in number from about 1 to 20. The width W of the knife edge 398 can range from about 0.2 mm to 5 mm. The length of the aspiration channel 245 can range from 1 mm to 10 mm and can be in curved or straight surfaces 252 about the aspiration port 245.

In another embodiment, referring to FIGS. 13A and 13B, an ablation system 400 can have an extension member 410 and working end 420 that has at least one flow outlet 170 for jetting flow media at a pressure and velocity configured to disintegrate or cut tissue. Like the working ends of FIGS. 7, 10 and 11 above, the working end 420 of FIG. 13A is rotatable at from 10 rpm to 10,000 rpm and by means of a motor drive 335 and controller 155. As can be seen in FIG. 13B, the working end 420 also is moveable axially by means of the motor drive and controller 155. Thus, the motor drive 335 and controller 155 can move the working end and flow outlets 170 in any pattern or sequence of angular, axial or helical motion to disintegrate, cut and ablate tissue.

In one aspect of the invention, the angular or axial movement of the flow outlet or outlets is controlled by controller 155 to limit the depth of tissue disintegration or cutting. It can be understood that at a selected flow pressure, fluid mass and flow velocity, the jetting of flow media can be configured to cut a selected depth until the flow pressure, velocity and mass is diminished and dispersed so as to longer disintegrate tissue. For example, in one embodiment, the jetted flow media from outlets 170 can have a flow pressure, mass and velocity that disintegrates tissue to a depth of 0.5 mm/s for a predetermine width of jetted flow media. In this embodiment, the working end 420 can have a circumference of 3.0 mm. Thus, rotating the working end of FIG. 13A and outlet at 60 rpm can provide a depth of tissue disintegration of 0.05 mm in a 360.degree. path for each revolution adjacent the flow outlet. By higher speed rotation, the depth of tissue disintegration can be controlled to provide selected thin depths of ablation. By rotating in a helical pattern, an elongated tissue disintegration and ablation can be provided adjacent each flow outlet.

Thus, on aspect of a method of the invention is to controllably rotate a working end outlet that jets flow media so that tissue is disintegrated to a depth of less than 1.0 mm for each 360.degree. revolution of the outlet, or less than 0.5 mm for each 360.degree. revolution of the outlet or less than 0.1 mm for each 360.degree. revolution of the outlet. The method further comprises using a plurality of jets of flow media about parallel axes or converging axes as in the device of FIG. 7.

Referring to FIGS. 13A and 13B, the working end 420 also includes an extendable-retractable sleeve 440 with aspiration channel 444 and aspiration port 445 therein. It can be understood that the sleeve 440 can be moved over the region of flow outlets 170 to remove disintegrated tissue and flow media. The negative pressure source 240 communicates with aspiration channel 444 as in previous embodiments. In other embodiments, the distal end 448 of sleeve 440 and aspiration port 445 can be distally-facing, angled or the rotatable extension member 410 can be within a side-facing aspiration port as in the embodiments of FIGS. 7-9 above.

In another aspect of the invention in FIGS. 13A and 13B, it can be seen that first and second flow media sources 140 and 200 are coupled to at least one flow channels 450 in extension member to deliver first and second flow media 150 and/or 205 through outlets 170. In one embodiment, flows of the first and second media 150 and 205 are jetted through a single channel 450 in successive intervals to disintegrate and seal tissue outward of outlets 170. In another embodiment, a first media 150 comprising a water vapor is flowed continuously and a second media of liquid water is pulsed from outlets 170. In another embodiment, two independent flow channels are provided in the extension member 410 that leads to independent flow outlets 170 (not shown).

In another aspect of the invention, the working end 420, flow media sources 140 and 200 and controller 155 can provide a first controlled pressure that is greater than 5 psi, 10 psi, 20 psi, 30 psi, 40 psi, 50 psi, 100 psi, 200 psi, 500 psi or 1000 psi for disintegrating or cutting tissue. The flow media can be any high quality vapor, low quality vapor, water or saline solution. In such an embodiment, the system can provide a second controlled pressure that is less than 50 psi, 40 psi, 30 psi, 20 psi, 10 psi and 5 psi. In use, the flow media at the second controlled pressure applies heat for sealing tissue about the disintegrated tissue region.

Although particular embodiments of the present invention have been described above in detail, it will be understood that this description is merely for purposes of illustration and the above description of the invention is not exhaustive. Specific features of the invention are shown in some drawings and not in others, and this is for convenience only and any feature may be combined with another in accordance with the invention. A number of variations and alternatives will be apparent to one having ordinary skills in the art. Such alternatives and variations are intended to be included within the scope of the claims. Particular features that are presented in dependent claims can be combined and fall within the scope of the invention. The invention also encompasses embodiments as if dependent claims were alternatively written in a multiple dependent claim format with reference to other independent claims.

* * * * *